ARTICLE | Clinical News
Saphris asenapine regulatory update
August 3, 2009 7:00 AM UTC
FDA's Psychopharmacologic Drugs Advisory committee voted 12-0 that Saphris asenapine from Schering-Plough was safe and effective for acute treatment of manic or mixed episodes in adults with bipolar I...